These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1157 related articles for article (PubMed ID: 17460490)

  • 41. Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.
    Uibo O; Teesalu K; Metskula K; Reimand T; Saat R; Sillat T; Reimand K; Talvik T; Uibo R
    World J Gastroenterol; 2006 Mar; 12(9):1430-4. PubMed ID: 16552815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients.
    Vivas S; Ruiz de Morales JM; Martinez J; González MC; Martín S; Martín J; Cechini C; Olcoz JL
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):479-83. PubMed ID: 12702903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA-DQ genotyping combined with serological markers for the diagnosis of celiac disease: is intestinal biopsy still mandatory?
    Clouzeau-Girard H; Rebouissoux L; Taupin JL; Le Bail B; Kalach N; Michaud L; Dabadie A; Olives JP; Blanco P; Morali A; Moreau JF; Lamireau T
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):729-33. PubMed ID: 21593645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infertility and celiac disease: do we need more than one serological marker?
    Shamaly H; Mahameed A; Sharony A; Shamir R
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1184-8. PubMed ID: 15548153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods.
    Reeves GE; Burns C; Hall ST; Gleeson M; Lemmert K; Clancy RL
    Pathology; 2000 Aug; 32(3):181-5. PubMed ID: 10968391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives.
    Bonamico M; Ferri M; Mariani P; Nenna R; Thanasi E; Luparia RP; Picarelli A; Magliocca FM; Mora B; Bardella MT; Verrienti A; Fiore B; Uccini S; Megiorni F; Mazzilli MC; Tiberti C
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):150-4. PubMed ID: 16456406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21.
    Castro M; Crinò A; Papadatou B; Purpura M; Giannotti A; Ferretti F; Colistro F; Mottola L; Digilio MC; Lucidi V
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):265-8. PubMed ID: 8492253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
    Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of anti-endomysium and anti-transglutaminase antibodies in the diagnosis and follow-up of celiac disease].
    Di Domenico MR; Annaluisa S; Pluvio R; Iovine C; Rea F
    Pediatr Med Chir; 2002; 24(3):208-12. PubMed ID: 12236034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
    Lo Iacono O; Petta S; Venezia G; Di Marco V; Tarantino G; Barbaria F; Mineo C; De Lisi S; Almasio PL; Craxì A
    Am J Gastroenterol; 2005 Nov; 100(11):2472-7. PubMed ID: 16279902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
    Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study.
    Gomez JC; Selvaggio G; Pizarro B; Viola MJ; La Motta G; Smecuol E; Castelletto R; Echeverria R; Vazquez H; Mazure R; Crivelli A; Sugai E; Mauriño E; Bai JC
    Am J Gastroenterol; 2002 Nov; 97(11):2785-90. PubMed ID: 12425549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Celiac disease in children with Down's syndrome].
    Lazzari R; Collina A; Arena G; Corvaglia L; Marzatico M; Vallini M; Bochicchio A; Pasetti A; Frassineti S; Forchielli L
    Pediatr Med Chir; 1994; 16(5):467-70. PubMed ID: 7885956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Transglutaminase antibody: usefulness in the diagnosis of celiac disease].
    Palacios Sarrasqueta M ; Rivero Marcotegui A ; SánchezValverde Visus F ; Feijoo Blanco E ; Ramos Arroyo M ; Olivera Olmedo J ; García Merlo S
    An Esp Pediatr; 2000 Dec; 53(6):542-6. PubMed ID: 11148151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein A and protein G ELISA for the detection of IgG autoantibodies against tissue transglutaminase in childhood celiac disease.
    Dahlbom I; Agardh D; Hansson T
    Clin Chim Acta; 2008 Sep; 395(1-2):72-6. PubMed ID: 18514068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis.
    Kumar V; Jarzabek-Chorzelska M; Sulej J; Rajadhyaksha M; Jablonska S
    Clin Immunol; 2001 Mar; 98(3):378-82. PubMed ID: 11237562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue transglutaminase antibodies in patients with end-stage heart failure.
    Peracchi M; Trovato C; Longhi M; Gasparin M; Conte D; Tarantino C; Prati D; Bardella MT
    Am J Gastroenterol; 2002 Nov; 97(11):2850-4. PubMed ID: 12425559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
    Bao F; Yu L; Babu S; Wang T; Hoffenberg EJ; Rewers M; Eisenbarth GS
    J Autoimmun; 1999 Aug; 13(1):143-8. PubMed ID: 10441179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
    Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.